Literature DB >> 24238151

Pre-eclampsia affects cord blood NK cell expression of activation receptors and serum cytokine levels but not CB monocyte characteristics.

Ebba Sohlberg1, Shanie Saghafian-Hedengren, Nora Bachmayer, Rangeen Rafik Hamad, Katarina Bremme, Ulrika Holmlund.   

Abstract

PROBLEM: Maternal immunopathology in pre-eclampsia is well studied; however, less is known regarding the immunological effects on the newborns. Increased inflammation and activation of immune cells at the fetal-maternal interface in pre-eclampsia could influence the neonatal immune compartment. METHOD OF STUDY: Monocytes and natural killer (NK) cells from cord blood (CB) of children with pre-eclamptic or healthy mothers were analyzed by flow cytometry for surface markers and intracellular cytokines. In addition, serum cytokine profiles were investigated using ELISA or cytometric bead array.
RESULTS: Neonates born to pre-eclamptic mothers had an inflammatory serum cytokine profile. While CB monocyte characteristics seemed unaffected, CB NK cells from pre-eclamptic pregnancies had higher NKp30, but borderline lower NKG2D expression.
CONCLUSION: In utero inflammatory priming of neonatal innate immunity taking place in pre-eclamptic pregnancies might influence specific NK cell functions in newborns.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cytokines; NKG2D; NKp30; innate immunity; monocytes; newborns

Mesh:

Substances:

Year:  2013        PMID: 24238151     DOI: 10.1111/aji.12169

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  2 in total

1.  Genome-scale hypomethylation in the cord blood DNAs associated with early onset preeclampsia.

Authors:  Travers Ching; James Ha; Min-Ae Song; Maarit Tiirikainen; Janos Molnar; Marla J Berry; Dena Towner; Lana X Garmire
Journal:  Clin Epigenetics       Date:  2015-03-13       Impact factor: 6.551

2.  Preeclampsia is Characterized by Fetal NK Cell Activation and a Reduction in Regulatory T Cells.

Authors:  Andrea I Loewendorf; Tina A Nguyen; Maria N Yesayan; Daniel A Kahn
Journal:  Am J Reprod Immunol       Date:  2015-05-10       Impact factor: 3.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.